Nuveen, LLC Sellas Life Sciences Group, Inc. Transaction History

Nuveen, LLC

$348 Billion
Q2 2025

A detailed history of Nuveen, LLC transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 971,329 shares of SLS stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

971,329

Holding current value

$1.56 Million

% of portfolio

0.0%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 12, 2025	BUY	$1.04 - $2.19 $1.01 Million - $2.13 Million	971,329 New	971,329 $2.13 Million

Others Institutions Holding SLS

# of Institutions

Shares Held

25.3M

Call Options Held

538K

Put Options Held

26.3K

Anson Funds Management LP Dallas, TX

7.58M
Shares

$12.2 Million
1.95% of portfolio
Vanguard Group Inc Valley Forge, PA

6.65M
Shares

$10.7 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.72M
Shares

$4.37 Million
0.01% of portfolio
Geode Capital Management, LLC Boston, MA

2.2M
Shares

$3.54 Million
0.0% of portfolio
Northern Trust Corp Chicago, IL

698K
Shares

$1.12 Million
0.0% of portfolio

View Full List

About SELLAS Life Sciences Group, Inc.

Ticker SLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,551,900
Market Cap $33.1M
Description
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...

More about SLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.

Account